|
PF-8698 |
TABALON 400, 400 mg, Tabletas Recubiertas |
2008-11-11 |
|
|
Guatemala
|
Sanofi-Aventis de Guatemala, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-32409 |
SERTAL Compuesto Grageas |
2009-03-31 |
|
Roemmers De Centro America S.A. |
Guatemala
|
Roemmers De Centro America S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-13762 |
RULIDE 300 mg Tabletas Recubiertas |
2009-07-20 |
|
|
Guatemala
|
Sanofi-Aventis de Guatemala, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-13802 |
NEOFLAX 4 mg Tabletas |
2009-07-29 |
|
|
Guatemala
|
Farmaceutica Industrial S.A. (infarma) |
Sanofi-Aventis de Guatemala, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-15417 |
AMARYL 4 mg Tabletas |
2009-09-24 |
|
|
Guatemala
|
Sanofi-Aventis de Guatemala, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-28300 |
STEMETIL 5 mg tabletas |
2007-08-02 |
|
|
Reino Unido
|
Sanofi-Aventis de Guatemala, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-38723 |
NEOFLAX 1 mg/1mL Solución Inyectable |
2017-04-18 |
|
Sanofi-Aventis de Guatemala, S.A. |
Guatemala
|
Sanofi-Aventis De Guatemala |
Agencias J.I. Cohen |
DASA |
Droguería Y Farmacia Lanquetin |
Bodega Farmacéutica, S.A. |
Agefinsa (Agencia Farm. Intern., S.A.) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-28841 |
NEOFLAX 4.0 mg/2 mL solución inyectable |
2012-10-01 |
|
Sanofi-Aventis de Guatemala, S.A. |
Guatemala
|
Agefinsa (Agencia Farm. Intern., S.A.) |
Lanquetin S.A. |
Sanofi-Aventis de Guatemala, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-5156 |
ACON 50,000 UI Capsulas |
2014-10-09 |
|
Sanofi-Aventis de México, S.A. de C.V. |
Guatemala
|
Agencias J.I. Cohen |
Agefinsa (Agencia Farm. Intern., S.A.) |
Centro Distribuidor, S.A. |
Lanquetin S.A. |
Sanofi-Aventis de Guatemala, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-38371 |
LASILACTON Cápsulas |
2021-09-30 |
|
Sanofi-Aventis de México, S.A. de C.V. |
Mexico
|
Sanofi-Aventis De Guatemala |
J.I.Cohen, S.A. |
Agencias J. I. Cohen |
Agencias J.I. Cohen |
DASA |
Droguería Y Farmacia Lanquetin |
Agefinsa |
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|